Fiduciary Alliance LLC Grows Holdings in Oscar Health, Inc. $OSCR

Key Points

• Fiduciary Alliance LLC has significantly increased its holdings in Oscar Health, Inc. by 3,558.0%, acquiring a total of 453,588 shares valued at approximately $9.7 million as of the latest SEC filing.
• Multiple analysts have downgraded Oscar Health's stock ratings, with Wall Street Zen and UBS Group both issuing sell ratings and lowering price targets to around $11.00.
• Oscar Health reported a 29.0% increase in revenue year-over-year, reaching $2.86 billion, despite a slight miss on earnings expectations.

Fiduciary Alliance LLC increased its holdings in Oscar Health, Inc. (NYSE:OSCR - Free Report) by 3,558.0% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 453,588 shares of the company's stock after acquiring an additional 441,188 shares during the quarter. Fiduciary Alliance LLC owned about 0.18% of Oscar Health worth $9,725,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds have also bought and sold shares of the company. BNP Paribas Financial Markets purchased a new position in shares of Oscar Health during the fourth quarter valued at approximately $590,000. Cetera Investment Advisers grew its stake in shares of Oscar Health by 17.1% in the 4th quarter. Cetera Investment Advisers now owns 27,066 shares of the company's stock worth $364,000 after buying an additional 3,961 shares during the last quarter. Deutsche Bank AG increased its position in Oscar Health by 51.2% during the 4th quarter. Deutsche Bank AG now owns 172,127 shares of the company's stock valued at $2,313,000 after buying an additional 58,282 shares in the last quarter. Focus Partners Wealth purchased a new position in Oscar Health during the fourth quarter valued at $729,000. Finally, Nuveen Asset Management LLC raised its stake in Oscar Health by 1.0% during the fourth quarter. Nuveen Asset Management LLC now owns 2,356,298 shares of the company's stock valued at $31,669,000 after buying an additional 23,237 shares during the last quarter. Institutional investors own 75.70% of the company's stock.

Analyst Upgrades and Downgrades

A number of research firms have recently commented on OSCR. Raymond James Financial cut Oscar Health from an "outperform" rating to a "market perform" rating in a research note on Tuesday, June 24th. Wells Fargo & Company cut shares of Oscar Health from an "equal weight" rating to an "underweight" rating and dropped their price target for the stock from $16.00 to $10.00 in a research note on Friday, July 11th. Wall Street Zen downgraded shares of Oscar Health from a "hold" rating to a "sell" rating in a research report on Saturday, August 9th. Barclays decreased their target price on shares of Oscar Health from $17.00 to $11.00 and set an "underweight" rating for the company in a report on Wednesday, July 23rd. Finally, UBS Group reiterated a "sell" rating and issued a $11.00 target price (down previously from $15.00) on shares of Oscar Health in a research note on Tuesday, July 15th. Four research analysts have rated the stock with a Hold rating and five have given a Sell rating to the company. According to MarketBeat, the stock currently has an average rating of "Strong Sell" and a consensus target price of $12.07.

Oscar Health Trading Down 3.0%

Shares of OSCR stock opened at $18.75 on Tuesday. The company has a current ratio of 0.86, a quick ratio of 0.86 and a debt-to-equity ratio of 0.26. Oscar Health, Inc. has a 12-month low of $11.20 and a 12-month high of $23.79. The stock has a market capitalization of $4.85 billion, a P/E ratio of -23.15 and a beta of 1.87. The firm's 50 day moving average is $15.96 and its 200 day moving average is $15.18.

Oscar Health (NYSE:OSCR - Get Free Report) last released its quarterly earnings results on Wednesday, August 6th. The company reported ($0.89) earnings per share for the quarter, beating the consensus estimate of ($0.90) by $0.01. Oscar Health had a negative return on equity of 13.78% and a negative net margin of 1.50%.The firm had revenue of $2.86 billion for the quarter, compared to analysts' expectations of $2.88 billion. During the same period in the prior year, the firm earned $0.20 EPS. The company's revenue was up 29.0% compared to the same quarter last year. Research analysts expect that Oscar Health, Inc. will post 0.69 earnings per share for the current year.

Oscar Health Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.

Want to see what other hedge funds are holding OSCR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Oscar Health, Inc. (NYSE:OSCR - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.